Abbott Laboratories
NYSE:ABT

Watchlist Manager
Abbott Laboratories Logo
Abbott Laboratories
NYSE:ABT
Watchlist
Price: 117.76 USD 0.43% Market Closed
Market Cap: 204.3B USD
Have any thoughts about
Abbott Laboratories?
Write Note

Net Margin
Abbott Laboratories

14%
Current
15%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
14%
=
Net Income
5.8B
/
Revenue
41.2B

Net Margin Across Competitors

Country US
Market Cap 204.9B USD
Net Margin
14%
Country US
Market Cap 195.2B USD
Net Margin
29%
Country US
Market Cap 146.7B USD
Net Margin
16%
Country US
Market Cap 132.6B USD
Net Margin
11%
Country IE
Market Cap 110.6B USD
Net Margin
12%
Country US
Market Cap 64.7B USD
Net Margin
9%
Country DE
Market Cap 55.6B EUR
Net Margin
8%
Country CN
Market Cap 319.2B CNY
Net Margin
34%
Country US
Market Cap 41.6B USD
Net Margin
74%
Country US
Market Cap 37.7B USD
Net Margin
9%
Country US
Market Cap 35.8B USD
Net Margin
23%
No Stocks Found

Abbott Laboratories
Glance View

Market Cap
204.9B USD
Industry
Health Care

Abbott Laboratories, a global leader in the healthcare industry, has a storied history dating back to its founding in 1888 by Dr. Wallace Abbott. The company is renowned for its dedication to improving health through innovative products that span several key segments: diagnostics, medical devices, nutrition, and branded generic pharmaceuticals. With a robust portfolio that includes cutting-edge technologies such as continuous glucose monitoring systems and rapid COVID-19 tests, Abbott has positioned itself as a vital player in both consumer and professional healthcare arenas. Its commitment to research and development, capturing nearly $2 billion in annual investment, underscores the company's strategic focus on innovation and long-term growth, making it an attractive option for investors seeking stability and upward trajectory in the healthcare sector. Abbott's diverse product offerings and strong market presence provide a solid foundation for its financial performance, which has consistently demonstrated resilience and growth across economic cycles. The company's ability to adapt to changing healthcare needs—exemplified by its rapid response to the COVID-19 pandemic with the development of at-home testing solutions—highlights its proactive approach and operational agility. In addition to its impressive revenue streams, Abbott pays a growing dividend, appealing to income-focused investors. With a clear vision for the future, bolstered by global expansion and strategic acquisitions, Abbott Laboratories is not just a company that manufactures healthcare products; it is a catalyst for positive change in health and well-being, making it a compelling investment opportunity for those looking to capitalize on the ever-evolving healthcare landscape.

ABT Intrinsic Value
100.13 USD
Overvaluation 15%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
14%
=
Net Income
5.8B
/
Revenue
41.2B
What is the Net Margin of Abbott Laboratories?

Based on Abbott Laboratories's most recent financial statements, the company has Net Margin of 14%.